Picture of Kidswell Bio logo

4584 — Kidswell Bio News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Gene Techno Science commences phase III clinical trial for renal anemia treatment drug

Sept 16 (Reuters) - Gene Techno Science Co Ltd  4584.T : 
     
    * Says it commenced the phase III clinical trial for a renal 
anemia treatment drug in Japan 
    * Says the drug is jointly developing by the co and SANWA 
KAGAKU KENKYUSHO 
     
     
    Source text in Japanese: https://goo.gl/8oxflg 
    Further company Coverage:  4584.T  
 
 (Beijing Headline News) 
 ((Beijing.HeadlineNews@thomsonreuters.com; +86 010 62674724; 
Reuters Messaging: qiujing.li.thomsonreuters.com@reuters.net))

Recent news on Kidswell Bio

See all news